| Product name | Type | Clinical application | Sample Type | Reaction Time | Applicable Models | Methodology | Specifications | |||||
| FPV/FCV/FHV Ab | Immunization effectiveness assessment | Evaluation of the effectivenessof the feline parvovirus/feline herpes/felinecalicivirus vaccine | Serum, Plasma | 10min | New Model: FIC-NTIMM3
Previous Model: NTIMM4/NTIMM2 |
Rare earth nanocrystalline fluorescence Immunochromatography | 10 tests/box | |||||
| Product Name | Type | Subprojects | Clinical Application | Sample Type | Reaction Time | Applicable Models | Methodology | Specifications |
| ICHV/CPV/CDV/CPIV/CCV Ab | Immunization effectiveness assessment | CPV Ab | Evaluation of immune effect to canine parvovirus vaccine;Confirmation of CPV infection | Serum, Plasma
|
10min | New Model: FIC-NTIMM3
Previous Model: NTIMM4/NTIMM2 |
Rare earth nanocrystalline fluorescence Immunochromatography | 10 tests/box |
| CDV Ab | Evaluation of immune effect to canine distemper virus vaccine ,and post-infection surveillance | |||||||
| CAV Ab | Evaluation of immune effect to Canine adenovirus vaccine;Confirmation of CAV infection | |||||||
| CPIV Ab | Evaluation of immunological effect to canine parainfluenza vaccine;Confirmation of CPIV infection | |||||||
| ICHV Ab |
Evaluation of immuno status of canine ICHV IgG antibody. Confirming of ICHV infection. |
|||||||
| CCV Ab | Evaluation of immunological effect to Canine Coronavirus vaccine. |
|
Product name
|
Type | Clinical application | Sample Type | Reaction Time | Applicable Models | Methodology | Specifications | |||||
| ICHV/CPV/CDV Ab | Immunization effectiveness assessment | Evaluation of the effectiveness of the Canine Parvovirus/Canine Distemper Virus/Canine Adenovirus vaccine | Serum, Plasma | 10min | New Model: FIC-NTIMM3
Previous Model: NTIMM4/NTIMM2 |
Rare earth nanocrystalline fluorescence Immunochromatography | 10 tests/box | |||||
